Zoetis (ZTS) Change in Receivables (2014 - 2026)

Zoetis' (ZTS) quarterly Change in Receivables came in at $106.0 million in Q1 2026, up 130.43% year-on-year from $46.0 million in Q1 2025, and up 103.85% on a QoQ basis from $52.0 million in Q4 2025.

Zoetis (ZTS) Change in Receivables (2014 - 2026) Analysis & Trends

Zoetis (ZTS) has 13 years of Change in Receivables data on file, last reported at $106.0 million in Q1 2026.

  • On a quarterly basis, Change in Receivables rose 130.43% year-over-year to $106.0 million in Q1 2026; TTM through Mar 2026 was $296.0 million, a 211.58% increase from a year earlier, with the FY2025 full-year figure at $236.0 million, up 286.89% from the prior year.
  • Change in Receivables for Q1 2026 stood at $106.0 million, up from $52.0 million in the prior quarter.
  • Over the last five years, Change in Receivables for ZTS reached as high as $148.0 million in Q2 2025 and fell as low as -$73.0 million in Q4 2024.
  • Historically, Change in Receivables has averaged $37.8 million across 5 years, with a median of $46.0 million in 2025.
  • Across the five-year window, Change in Receivables sank 933.33% in 2022 and soared 283.33% in 2025, its largest moves.
  • Year by year, Change in Receivables stood at $17.0 million in 2022, then surged by 182.35% to $48.0 million in 2023, then sank by 252.08% to -$73.0 million in 2024, then soared by 171.23% to $52.0 million in 2025, then soared by 103.85% to $106.0 million in 2026.
  • Per Business Quant data, the three most recent Change in Receivables figures were $106.0 million in Q1 2026, $52.0 million in Q4 2025, and -$10.0 million in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Change in Receivables (Qtr)
1 Haleon 88.07 Bn 86.20 Bn - -
2 Teva Pharmaceutical Industries 35.75 Bn 32.01 Bn 1.97 Bn -78.00 Mn
3 Zoetis 31.84 Bn 29.90 Bn 1.62 Bn 106.00 Mn
4 Takeda Pharmaceutical 27.18 Bn 23.12 Bn 4.39 Bn -621.82 Mn
5 United Therapeutics 23.09 Bn 20.93 Bn 648.10 Mn -38.20 Mn
6 RedHill Biopharma 21.32 Bn 21.32 Bn - -
7 Viatris 19.96 Bn 18.16 Bn 1.16 Bn 126.30 Mn
8 Neurocrine Biosciences 17.66 Bn 16.34 Bn 800.70 Mn 81.40 Mn
9 Elanco Animal Health 12.44 Bn 12.02 Bn 785.00 Mn -
10 Vireo Growth 10.53 Bn 10.38 Bn 59.30 Mn 1.10 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 106.00 Mn
Mar 31, 2026 106.00 Mn
Dec 31, 2025 52.00 Mn
Dec 31, 2025 52.00 Mn
Sep 30, 2025 -10.00 Mn
Sep 30, 2025 -10.00 Mn
Jun 30, 2025 148.00 Mn
Jun 30, 2025 148.00 Mn
Mar 31, 2025 46.00 Mn
Mar 31, 2025 46.00 Mn
Dec 31, 2024 -73.00 Mn
Dec 31, 2024 -73.00 Mn
Sep 30, 2024 22.00 Mn
Sep 30, 2024 22.00 Mn
Jun 30, 2024 100.00 Mn
Jun 30, 2024 100.00 Mn
Mar 31, 2024 12.00 Mn
Mar 31, 2024 12.00 Mn
Dec 31, 2023 48.00 Mn
Dec 31, 2023 48.00 Mn